Showing 1 to 15 of 145 entries
TOP PICK
Healthcare gives you the combination of defence and offence. Largest managed care provider in the US. Medical insurance, pharma benefits, and healthcare services create a strong value proposition to its customers. This will lead to steadily and reliable sales. Last quarter, easily beat expectations and raised earnings guidance for the full year. Earnings growth should top 12% over the next few years. Yield is 1.26%, will grow over time. (Analysts’ price target is $579.00)
medical services
BUY
This one has many major components, and all are growing nicely. Growth expected at 15% this year and next. Small dividend, growing double digits. Ultimately, legislative is supportive of these companies. Great performer in a tough market. He'd buy here, great risk/reward. Though if the market recovers quickly, it may not outperform in the near term.
medical services
BUY
A go-to name, core holding. Because it's the largest in the US, it won't get caught offside by upcoming regulatory changes, the way a smaller company would. Pretty consistent grower at 15-20% per year.
medical services
BUY
Healthcare is his biggest sector. HC is seeing the classic shift to defensives as inflation peaks. Also, HC trades at only 18x while utilities and staples trade at 21x, so it's the cheapest defensive. He owns Pfizer, UNH and Regeneron. UNH's revenue and EPS beat recently. Healthcare has so many tailwinds, including again demographics. He likes preventative healthcare and UNH's position here. HC is fine in the late cycle. There's still to the upside here.
medical services
BUY
They report Friday and should have a great quarter, because Covid isn't as threatening as before. There is some cyclicality. If there are alot of layoffs, their numbers can weaken, but he doesn't see that now. Otherwise, keep buying, though he prefers the cheaper Humana.
medical services
PAST TOP PICK
(A Top Pick Jun 24/21, Up 27%) Adding to it. Is American's largest healthcare insurer and healthcare services. This synergy is great for customers. Also, healthcare offers defense as well as growth. Chart is trending upwards as the market goes down.
medical services
PAST TOP PICK
(A Top Pick Oct 20/20, Up 52%) Great business. Dominant player in managed care. GARP. Executing exceptionally well, consistent.
medical services
COMMENT
It beat two weeks ago, but it has struggled since then, because markets won't pay for future earnings. Not UNH's fault.
medical services
BUY
Healthcare has historically been a top sector after a yield curve inversion, when people get defensive. UNH dominates in commercial health, Medicare and Medicaid.
medical services
Unspecified
Has owned for many years. It is the best play in managed health care and helps payers and payees be more efficient and lower health care costs. Acquires and tucks in acquisitions. Highly innovative and very well managed. Maybe trading a bit on the rich side.
medical services
HOLD
An 800-pound gorilla. He'll continue to own it. Controlled costs by putting risk and responsibility on the actual providers of the healthcare services. Incentivizing to control costs at the local level. Short term, you may see costs spike due to pandemic-delayed visits. Medium-long term, you'll be fine.
medical services
BUY
It hit a new high today and he's long. It's reasonably valued. He targets at least $550.
medical services
HOLD
Likes it. EBV +6, means the stock price is pounding away. Stock could easily go to $650. Model price of $385.81, so it's too expensive by 22%. But any correction back to around $387, he'd buy.
medical services
SELL
Very good company, but not as good a stock because of valuation. He owns ANTM instead, trading about 6 multiple points less than UNH, with equally good growth metrics. Higher multiple stocks are selling off. Neither has supply chain issues.
medical services
TOP PICK
Clouds of macro risk. This one has consistently had visibility into its business. The most vertically integrated managed care company. Best in class GARP in healthcare. Administer a lot of Medicare and Medicaid. Bipartisan support for a lot of their programs. A consistent performer. Yield is 1.17%. (Analysts’ price target is $530.93)
medical services
Showing 1 to 15 of 145 entries

UnitedHealth Group Inc(UNH-N) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 11

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 3

Total Signals / Votes : 16

Stockchase rating for UnitedHealth Group Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

UnitedHealth Group Inc(UNH-N) Frequently Asked Questions

What is UnitedHealth Group Inc stock symbol?

UnitedHealth Group Inc is a American stock, trading under the symbol UNH-N on the New York Stock Exchange (UNH). It is usually referred to as NYSE:UNH or UNH-N

Is UnitedHealth Group Inc a buy or a sell?

In the last year, 16 stock analysts published opinions about UNH-N. 11 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for UnitedHealth Group Inc.

Is UnitedHealth Group Inc a good investment or a top pick?

UnitedHealth Group Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for UnitedHealth Group Inc.

Why is UnitedHealth Group Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is UnitedHealth Group Inc worth watching?

16 stock analysts on Stockchase covered UnitedHealth Group Inc In the last year. It is a trending stock that is worth watching.

What is UnitedHealth Group Inc stock price?

On 2022-09-30, UnitedHealth Group Inc (UNH-N) stock closed at a price of $505.04.